Search results
Showing 1 to 12 of 12 results for cg178
Psychosis and schizophrenia in adults: prevention and management (CG178)
This guideline covers recognising and managing psychosis and schizophrenia in adults. It aims to improve care through early recognition and treatment, and by focusing on long-term recovery. It also recommends checking for coexisting health problems and providing support for family members and carers.
This quality standard covers treating and managing psychosis and schizophrenia in adults (aged 18 and over) in primary, secondary and community care. It also includes support for the families and carers of people with psychosis or schizophrenia. It describes high-quality care in priority areas for improvement.
View quality statements for QS80Show all sections
Sections for QS80
- Quality statements
- Quality statement 1: Referral to early intervention in psychosis services
- Quality statement 2: Cognitive behavioural therapy
- Quality statement 3: Family intervention
- Quality statement 4: Treatment with clozapine
- Quality statement 5: Supported employment programmes
- Quality statement 6: Assessing physical health
- Quality statement 7: Promoting healthy eating, physical activity and smoking cessation
Recommendation ID CG178/2 Question People who choose not to take antipsychotic medication:- What is the clinical and cost effectiveness
Recommendation ID CG178/5 Question Interventions for PTSD symptoms in people with psychosis and schizophrenia:- What is the benefit of
Recommendation ID CG178/4 Question Maintaining the benefits of early intervention in psychosis services after discharge:- How can the...
Recommendation ID CG178/3 Question The physical health benefits of discontinuing antipsychotic medication:- What are the short- and...
Recommendation ID CG178/1 Question Peer support interventions:- What is the clinical and cost effectiveness of peer support interventions
Schizophrenia: aripiprazole prolonged-release suspension for injection (ESNM39)
This evidence summary has been updated and replaced by the NICE guideline CG178 (published February 2014).
This guidance has been updated and replaced by NICE guideline CG178. This guideline updates and replaces NICE guideline CG1.
This quality standard covers promoting health and preventing premature mortality among black, Asian and other minority ethnic groups. It is relevant to all age groups and all settings.
View quality statements for QS167Show all sections
Sections for QS167
- Quality statements
- Quality statement 1: Designing health and wellbeing programmes
- Quality statement 2: Peer and lay roles
- Quality statement 3: Referring people at high risk of type 2 diabetes
- Quality statement 4: Cardiac rehabilitation
- Quality statement 5: Support for people with mental health problems
- Quality statement 6: Physical health checks for people with serious mental illness
- Update information
Our health inequalities guidance supports strategies that improve population health as a whole, while offering particular benefit to the most disadvantaged
CG178/1 | Peer support interventions:- What is the clinical and cost effectiveness